Page last updated: 2024-08-25

nedaplatin and Experimental Hepatoma

nedaplatin has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, S; Lu, H; Sun, K; Taylor, EW; Wan, X; Wang, D; Wang, Y; Zhang, J	1

Other Studies

1 other study(ies) available for nedaplatin and Experimental Hepatoma

Article	Year
Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase. Toxicology and applied pharmacology, 2012, Dec-15, Volume: 265, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione; Liver Neoplasms, Experimental; Male; Mice; Organoplatinum Compounds; Random Allocation; Thioredoxin-Disulfide Reductase	2012

Article

Year

Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.

Toxicology and applied pharmacology, 2012, Dec-15, Volume: 265, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione; Liver Neoplasms, Experimental; Male; Mice; Organoplatinum Compounds; Random Allocation; Thioredoxin-Disulfide Reductase

2012